Green, Justin, Khanduja, Vikas and Malviya, Ajay (2025) EP2.18 Validating MCID and SCB thresholds in the Hip Arthroscopy Outcomes: A Study using the UK Non-Arthroplasty Hip Registry iHOT-12 Outcomes Scores in Femoroacetabular Impingement Patients. Journal of Hip Preservation Surgery, 12 (Supple). i60-i61. ISSN 2054-8397
Document
-
hnaf011.194.pdf
Available under License Creative Commons Attribution Non-commercial.
Abstract
Abstract
Introduction: The concept of the Minimal Clinically Important Difference (MCID) and Substantial Clinical Benefit (SCB) are thresholds in the assessment of clinical outcomes. Defined as the smallest change in a treatment outcome that a patient would identify as important, MCID establishes a threshold for clinical significance, beyond the mere statistical difference while SCB is considers as threshold for substantial improvement. Using the British Hip Society Non-Arthroplasty Hip Registry, this study aimed to validate the MCID for the international Hip Outcome Tool 12 (iHOT12), a tool designed to measure changes in patient-reported outcome measures (PROMS) following arthroscopic intervention for Femoroacetabular impingement (FAI). Method: The study analysed the data of 5590 patients recorded in the NAHR who underwent primary hip arthroscopic treatment for FAI between November 2013 and July 2023. Using the change in score between baseline and follow up a MCID threshold of 13 point gain, and a SCB score of 28 as defined previously (Holleyman et al), the change in score in NAHR records was evaluated to establish the viability of these thresholds Results: Of the eligible patients, 43.8%% (2450) had completed both the baseline iHOT12 survey and follow-up survey at 1 year. The average iHOT12 score at baseline and 1 year 32.69 (17.79 SD) and 58.54 (27.79) respectively. The number of patients who achieved the threshold for MCID were 1587 (64.7%), and for SCB were 1128 (46%). Conclusion: The results of our study affirm the MCID and SCB values reinforce the relevance of distribution-based methods in defining clinically significant changes in iHOT12 score. Based on our findings, we advocate for the adoption of a MCID values of 13.6 and a SCB of 28 when utilising the iHOT12 score in determining acceptable outcomes. This recommendation is grounded in the need for a practical and clinically meaningful threshold that resonates with patient perception of change.
| Item Type: | Article |
|---|---|
| Additional Information: | ** From Oxford University Press via Jisc Publications Router ** History: cover 01-03-2025; collection 27-03-2025; epub 27-03-2025. ** Licence for this article: https://creativecommons.org/licenses/by-nc/4.0/ |
| Related URLs: | |
| SWORD Depositor: | Publication Router |
| Depositing User: | Publication Router |
| URI: | https://sure.sunderland.ac.uk/id/eprint/18920 |
Further Details
More Information
Identifiers
Users with ORCIDS
Catalogue record
Contributors
University Divisions
Subjects
Actions (login required)
Download Statistics
Downloads per month over past year

Dimensions
Dimensions